The aim of this call was to form a new part of the COVID-19 research program that would focus on the impact of the different vaccines being introduced. As vaccinations for COVID-19 started in Sweden in early 2021, with more than one type of vaccine, we aimed to coordinate funding to proposals with team science approaches focusing on exploring: (i) protective effectiveness and adverse reactions; or (ii) cellular and molecular immunological effects; and/or (iii) correlates between protection or adverse reactions and immune response profiles. As more specific examples, the program aims at addressing goals, such as those below:
Tentative budget for the call was up to 55 MSEK (depending on the quality and quantity of the proposals). The proposals should strive to achieve adequately large and epidemiologically and/or clinically well-defined study groups and samples sets. SciLifeLab wished to achieve harmonization of both the epidemiological and experimental designs and analytical methods across the funded research projects to create comparable datasets. Therefore, on a case by-case basis, we asked the applicants to amend their proposals to facilitate comparability and synergies at the program level, such as laboratory methods or consents for data sharing or matching designs with international and EU guidelines.
SciLifeLab was not able to support the launch of expensive nation-wide clinical studies or phase III studies of new vaccine candidates. However, if such studies were launched otherwise, this program could support the molecular analysis of samples from such studies. In the immunological projects, a substantial fraction of the budget was expected to go towards detailed cellular and molecular immune response analyses.
We expect research results, data, and methods, including code, to be released throughout the project according to the FAIR principles and as early as possible in the research process. The information sharing should be arranged with the COVID-19 data portal operated by SciLifeLab Data Centre. In particular, proposals based on patient material were asked to provide information about how samples would be made available for additional molecular profiling, and the efforts taken through consent collection and ethics approval to address data- and sample sharing.
Applications should specify how FAIR data sharing and open access publishing would be addressed, and any exceptions stated at the time of application. All approved projects were required to establish a data management plan (DMP) at the start of the project.
Team science applications by PIs at any Swedish university and collaborators in health care.
PIs were expected to acquire pertinent consents and ethical, regulatory, institutional and other permissions before projects start.
Suggested total budget per proposal was up to 7.5 MSEK.
Time period for funding: 2021-2022
Please note that the grant only covers OH costs up to 20% and a maximum coverage of 50% for LKP (payroll overhead) on personnel costs. The researcher(s) are responsible for the necessary co-funding needed at each university/department.
Application deadline: January 15, 2021
Review: SciLifeLab Management Group (pre-screening) followed by experts in the field
Decision by SciLifeLab Board: February 3, 2021
Communication to all applicants: March 18, 2021
We welcome questions on this new research program.
Please send them to firstname.lastname@example.org.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.